CAS 114726-49-7 Fmoc-Gly-Gly-OSu

Xa kev nug
CAS 114726-49-7 Fmoc-Gly-Gly-OSu
Paub meej
CAS: 114726-49-7 Nr
•Synonyms: Fmoc-Gly-Gly-OSu; Fmoc-Gly-Gly-NHS; N-(9-Fluorenylmethoxycarbonyl)-glycyl-glycine N-hydroxysuccinimide ester
•Core qauv: N-Fmoc tiv thaiv dipeptide activated ester nrog cov qauv Fmoc-Gly-Gly-OSu
(fluorenylmethoxycarbonyl-glycyl-glycine succinimidyl ester), muaj li ntawm ob glycine residues, N-terminus
tiv thaiv nrog Fmoc (9-fluorenylmethoxycarbonyl), C-terminus li N-hydroxysuccinimide (OSu/NHS) activated ester. Ib qho kev siv nruab nrab hauv peptide synthesis thiab bioconjugation, NHS ester tau txais txiaj ntsig zoo nrog cov thawj amines los tsim cov ntawv cog lus amide, siv hauv ADC linker synthesis, peptide chain elongation, thiab protein labeling. Thov hu rau peb kom paub meej!
Cov ntaub ntawv ntsig txog
•COA/MS/HPLC Report
•Peptide Dissolution thiab Cia Qhia
Kev faib tawm yam khoom
Kev xa tshuaj Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov chaw muag khoom ntawm cas 114726-49-7 fmoc-gly-gly-osu hauv Suav teb, kuj txhawb kev pabcuam kev cai. Zoo siab txais tos rau cov lag luam wholesale bulk zoo cas 114726-49-7 fmoc-gly-gly-osu los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe Fmoc-Gly-Gly-OSu
Kev piav qhia Fmoc-Gly-Gly-OSu (Fmoc-Gly-Gly-}NHS), tshuaj npe (2,5-dioxopyrrolidin-1- yl) 2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetate, yog N-Fmoc tiv thaiv dipeptide N-hydroxysuccinimide activated ester. Nws cov molecule muaj ob glycine residues, nrog rau N-terminal amino pawg tiv thaiv los ntawm ib pab pawg Fmoc (9-fluorenylmethoxycarbonyl) (xaiv tau nyob rau hauv cov xwm txheej yooj yim) thiab C-terminal carboxyl pab pawg ua haujlwm ua ib qho NHS reactivity zoo heev (OS) thawj amines (xws li lysine sab-chain amines, protein N-terminal amines, amine-hloov oligonucleotides, thiab lwm yam) nyob rau hauv cov mob me me los tsim cov nyiaj ruaj khov amide. Raws li ib qho kev siv nruab nrab hauv peptide synthesis thiab bioconjugation, Fmoc-Gly-Gly-OSu tuaj yeem siv los qhia Gly-Gly dipeptide units hauv solid-phase peptide synthesis, tsim cov linkers rau antibody-drug conjugates (ADCs), ua qhov chaw tshwj xeeb sau npe ntawm cov proteins / peptides, thiab lwm yam. Kev sib xyaw ua ke ntawm Fmoc tiv thaiv pab pawg thiab NHS activated ester muab kev hloov pauv tau yooj yim hauv kev sib xyaw ua ke, ua kom muaj kev tiv thaiv kev sib txuas sib txuas.
Peptide Purity (HPLC, %) Ntau dua lossis sib npaug li 98%
Cov mis mos molecular C₂₃H₂₁N₃O₇
Molecular Luj (Da) 451.43

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Qhov nruab nrab MW (Da) Daim ntawv ntsev Ntev (aa)
Fmoc-Gly-Gly-OSu Fmoc-Gly-Gly N-hydroxysuccinimide ester; peptide synthesis tsev thaiv Peptide synthesis reagent, SPPS intermediate, C-terminal activated ester, peptide saw elongation N-terminal Fmoc (9-fluorenylmethoxycarbonyl) tiv thaiv dipeptide nrog C-terminal OSu activation; Cov pab pawg carboxyl reactive heev rau kev taw qhia kev sib txuas thiab cov saw txuas ntxiv hauv Fmoc solid-phase peptide synthesis C₂₃H₂₁N₃O₇ 451.14 ~451.4 Dawb ester (synthetic intermediate) 2 (dipeptide derivative)

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Luv - Lub Sij Hawm Cia Kev daws teeb meem Khoom hmoov ruaj khov
PEB-FMG001 Dawb rau tawm -dawb crystalline hmoov Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb, nyob rau hauv inert gas. Aliquot rau cia. ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; kom qhuav thaum shipping. Nyob ruaj khov rau 7 hnub ntawm 4℃nyob rau hauv cov dej tsis muaj dej. Soluble nyob rau hauv DMF, DMSO, DCM thiab organic solvents; me ntsis soluble hauv cawv. rhiab heev rau dej, amines thiab bases; Nws yooj yim rau ester hydrolysis thiab Fmoc cleavage. ruaj khov rau 2 xyoos ntawm -20 degree, qhuav, tiv thaiv los ntawm lub teeb thiab nyob rau hauv inert roj.

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-FMG001 Fmoc-Gly-Gly-OSu, qhib lub tsev thaiv rau SPPS thiab peptide saw elongation Fmoc-Gly-Gly-OSu yog ib qho nquag siv ua haujlwm nruab nrab rau Fmoc solid-theem peptide synthesis. N-terminal Fmoc pab pawg tiv thaiv cov amine los ntawm kev tawm tsam sab, thaum C-terminal OSu qhib cov carboxyl ua ib pab pawg tawm tsam kom muaj txiaj ntsig zoo sib txuas nrog cov dawb amine ntawm cov amino acid tom ntej. Nws yog siv rau Fmoc-raws li SPPS, peptide N-terminal modification and protein conjugation, as a foundational reagent in peptide synthesis and modification. Peptide synthesis chemistry, solid{0}}theem peptide synthesis, protein conjugation chemistry, tshuaj chemistry, peptide hloov kho kev tshawb fawb Carboxyl activation coupling cov tshuaj tiv thaiv; Fmoc tiv thaiv zoo; peptide daim ntawv cog lus

 

 

 

 

 

 

 

 

 

Cim npe nrov: cas 114726-49-7 fmoc-gly-gly-osu, Tuam Tshoj cas 114726-49-7 fmoc-gly-gly-osu manufacturers, lwm tus neeg, Hoobkas

Xa kev nug